HPV-associated adenocarcinoma common type can be treated. Compared with squamous cell carcinoma of the uterine cervix, adenocarcinoma of the uterine cervix is a more specific pathologic type with a relatively higher degree of malignancy, and is classified into HPV-associated and non-HPV-associated. HPV-associated adenocarcinoma common type suggests a relationship between the development of the cancer and HPV infection, and its treatment is the same as other pathologic types of cervical cancer, with surgical removal of the uterus being the most basic treatment. The extent of hysterectomy needs to be determined according to the clinical stage of the cancer, and postoperative supplemental chemotherapy or radiotherapy is needed according to the pathologic risk factors. HPV-associated adenocarcinoma of the common type, even in the early stages, is not recommended for fertility preservation, and postoperative HPV treatment is also needed to prevent long-term HPV infection leading to vaginal stump cancer. The treatment of HPV-associated adenocarcinoma common type in clinic needs to be formulated after comprehensive evaluation by professional gynecologic oncologists.